| MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy R Ogawa, I Nakashima, T Takahashi, K Kaneko, T Akaishi, Y Takai, ... Neurology: Neuroimmunology & Neuroinflammation 4 (2), e322, 2017 | 378 | 2017 |
| MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study T Akaishi, DK Sato, I Nakashima, T Takeshita, T Takahashi, H Doi, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (4), 446-448, 2016 | 151 | 2016 |
| CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications K Kaneko, DK Sato, I Nakashima, R Ogawa, T Akaishi, Y Takai, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (9), 927-936, 2018 | 142 | 2018 |
| Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies K Kaneko, DK Sato, I Nakashima, S Nishiyama, S Tanaka, R Marignier, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (11), 1257-1259, 2016 | 104 | 2016 |
| Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica T Akaishi, I Nakashima, T Takeshita, S Mugikura, DK Sato, T Takahashi, ... Journal of neuroimmunology 293, 28-33, 2016 | 88 | 2016 |
| Neuromyelitis optica spectrum disorders T Akaishi, I Nakashima, DK Sato, T Takahashi, K Fujihara Neuroimaging Clinics 27 (2), 251-265, 2017 | 70 | 2017 |
| Different etiologies and prognoses of optic neuritis in demyelinating diseases T Akaishi, I Nakashima, T Takeshita, K Kaneko, S Mugikura, DK Sato, ... Journal of Neuroimmunology 299, 152-157, 2016 | 69 | 2016 |
| Difference in the source of anti-AQP4-IgG and anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder T Akaishi, T Takahashi, T Misu, K Kaneko, Y Takai, S Nishiyama, ... Neurology 97 (1), e1-e12, 2021 | 68 | 2021 |
| Early fast‐acting treatment strategy against generalized myasthenia gravis K Utsugisawa, Y Nagane, T Akaishi, Y Suzuki, T Imai, E Tsuda, N Minami, ... Muscle & nerve 55 (6), 794-801, 2017 | 59 | 2017 |
| Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica T Akaishi, I Nakashima, T Misu, K Fujihara, M Aoki Journal of neuroimmunology 283, 70-73, 2015 | 49 | 2015 |
| Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders T Akaishi, T Takahashi, T Misu, M Abe, T Ishii, J Fujimori, M Aoki, ... Scientific reports 10 (1), 13890, 2020 | 48 | 2020 |
| Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD) T Akaishi, T Takahashi, I Nakashima, M Abe, T Ishii, M Aoki, K Fujihara Journal of the Neurological Sciences 410, 116671, 2020 | 46 | 2020 |
| Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence T Akaishi, I Nakashima, T Takahashi, M Abe, T Ishii, M Aoki Neurology: Neuroimmunology & Neuroinflammation 7 (1), e640, 2019 | 41 | 2019 |
| Insights into the classification of myasthenia gravis T Akaishi, T Yamaguchi, Y Suzuki, Y Nagane, S Suzuki, H Murai, T Imai, ... PloS one 9 (9), e106757, 2014 | 41 | 2014 |
| Importance of the quotient of albumin, quotient of immunoglobulin G and Reibergram in inflammatory neurological disorders with disease‐specific patterns of blood–brain barrier … T Akaishi, K Narikawa, Y Suzuki, S Mitsuzawa, K Tsukita, H Kuroda, ... Neurology and clinical Neuroscience 3 (3), 94-100, 2015 | 39 | 2015 |
| Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica T Akaishi, K Kaneko, N Himori, T Takeshita, T Takahashi, T Nakazawa, ... Journal of neuroimmunology 313, 10-15, 2017 | 37 | 2017 |
| Rapid administration of high-dose intravenous methylprednisolone improves visual outcomes after optic neuritis in patients with AQP4-IgG-positive NMOSD T Akaishi, T Takeshita, N Himori, T Takahashi, T Misu, R Ogawa, ... Frontiers in Neurology 11, 932, 2020 | 34 | 2020 |
| Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein T Akaishi, DK Sato, T Takahashi, I Nakashima Neurochemistry International 130, 104319, 2019 | 34 | 2019 |
| Efficiency of antibody therapy in demyelinating diseases T Akaishi, I Nakashima International immunology 29 (7), 327-335, 2017 | 31 | 2017 |
| Response to treatment of myasthenia gravis according to clinical subtype T Akaishi, Y Suzuki, T Imai, E Tsuda, N Minami, Y Nagane, A Uzawa, ... BMC neurology 16, 1-10, 2016 | 30 | 2016 |
